# Prevalence Data Outlier Analysis Summary

**Analysis Date**: 2025-07-10 02:06:32  
**Dataset**: 4924 diseases with prevalence estimates  
**Data Source**: `data/03_processed/orpha/orphadata/orpha_prevalence/`

## 📊 **Executive Summary**


### Key Findings

- **Total Diseases Analyzed**: 4924 with valid prevalence estimates
- **Prevalence Range**: 0.5 to 500.0 per million
- **Distribution**: Highly right-skewed (median: 0.5, mean: 29.2)
- **Skewness**: 3.85 (highly right-skewed)
- **Kurtosis**: 15.13 (heavy-tailed distribution)

### Outlier Detection Results

| Method | Outliers Detected | Percentage | Upper Threshold |
|--------|------------------|------------|----------------|
| IQR Method | 1047 | 21.3% | 11.8 |
| Z-Score | 252 | 5.1% | 283.0 |
| Modified Z-Score | 0 | 0.0% | 0.5 |
| Log-Normal | 257 | 5.2% | 262.7 |
| Percentile | 247 | 5.0% | 293.2 |
| Medical Domain | 91 | 1.8% | Domain Rules |

### Consensus Outliers
- **High Confidence**: 28 diseases flagged by ≥4 methods
- **Medium Confidence**: 26 diseases flagged by 2-3 methods
- **Low Confidence**: 425 diseases flagged by 1 method


## 🔬 **Outlier Detection Methods Comparison**


### Method Characteristics

#### Statistical Methods
- **IQR Method**: Traditional box plot approach, good for symmetric distributions
- **Z-Score**: Assumes normal distribution, sensitive to extreme values
- **Modified Z-Score**: More robust to outliers, uses median and MAD
- **Log-Normal**: Appropriate for skewed biological data, transforms to log space
- **Percentile**: Distribution-free, uses empirical percentiles

#### Medical Domain Method
- **High Prevalence + Low Reliability**: Prevalence >100 per million with reliability <6.0
- **High Prevalence + Single Record**: Prevalence >100 per million with only 1 record
- **Exceeds Rare Disease Definition**: Prevalence >500 per million (EU definition)
- **Extremely High Prevalence**: Prevalence >1000 per million (0.1% of population)

### Method Recommendations
- **For Statistical Analysis**: Log-Normal method most appropriate for prevalence data
- **For Data Quality**: Medical Domain method identifies problematic records
- **For Conservative Filtering**: Modified Z-Score provides balanced approach
- **For Aggressive Filtering**: IQR method removes more outliers


## 📈 **Statistical Analysis Results**


### Distribution Characteristics
- **Mean**: 29.17 per million
- **Median**: 0.50 per million
- **Standard Deviation**: 84.62
- **Skewness**: 3.85 (highly right-skewed)
- **Kurtosis**: 15.13 (heavy-tailed)

### Quartile Analysis
- **Q1 (25th percentile)**: 0.50 per million
- **Q3 (75th percentile)**: 5.00 per million
- **IQR**: 4.50

### Extreme Values
- **Top 1%**: >500.00 per million
- **Top 5%**: >293.17 per million
- **Bottom 5%**: <0.50 per million


## 🏥 **Medical Domain Findings**


### Medical Domain Outlier Categories

#### High Prevalence + Low Reliability (19 diseases)
Diseases with prevalence >100 per million but reliability score <6.0. These may represent:
- Data quality issues
- Conflicting evidence
- Geographic bias in small studies

#### High Prevalence + Single Record (72 diseases)
Diseases with prevalence >100 per million based on only one record. These may represent:
- Insufficient evidence
- Preliminary findings
- Publication bias

#### Exceeds Rare Disease Definition (0 diseases)
Diseases with prevalence >500 per million (EU rare disease threshold). These may represent:
- Common conditions misclassified as rare
- Geographic variations
- Prevalence class mapping errors

#### Extremely High Prevalence (0 diseases)
Diseases with prevalence >1000 per million (0.1% of population). These likely represent:
- Data processing errors
- Prevalence type confusion (birth vs population)
- Geographic-specific conditions applied globally

### Top Medical Domain Outliers

1. **Cleft lip and alveolus** (Orpha: 141291)
   - Prevalence: 500.0 per million
   - Reliability: 4.0
   - Records: 1
   - Reason: High prevalence + low reliability

2. **Onchocerciasis** (Orpha: 2737)
   - Prevalence: 500.0 per million
   - Reliability: 4.0
   - Records: 2
   - Reason: High prevalence + low reliability

3. **Epidermolytic nevus** (Orpha: 497737)
   - Prevalence: 500.0 per million
   - Reliability: 6.8
   - Records: 1
   - Reason: High prevalence + single record

4. **Ectodermal dysplasia syndrome** (Orpha: 79373)
   - Prevalence: 500.0 per million
   - Reliability: 8.0
   - Records: 1
   - Reason: High prevalence + single record

5. **Von Willebrand disease type 1** (Orpha: 166078)
   - Prevalence: 300.0 per million
   - Reliability: 4.0
   - Records: 1
   - Reason: High prevalence + low reliability

6. **Dentinogenesis imperfecta type 2** (Orpha: 166260)
   - Prevalence: 300.0 per million
   - Reliability: 9.0
   - Records: 1
   - Reason: High prevalence + single record

7. **Photosensitive occipital lobe epilepsy** (Orpha: 166409)
   - Prevalence: 300.0 per million
   - Reliability: 9.0
   - Records: 1
   - Reason: High prevalence + single record

8. **Atopic keratoconjunctivitis** (Orpha: 163934)
   - Prevalence: 300.0 per million
   - Reliability: 8.0
   - Records: 1
   - Reason: High prevalence + single record

9. **Stargardt disease** (Orpha: 827)
   - Prevalence: 300.0 per million
   - Reliability: 8.0
   - Records: 1
   - Reason: High prevalence + single record

10. **Non-acquired isolated growth hormone deficiency** (Orpha: 631)
   - Prevalence: 300.0 per million
   - Reliability: 6.0
   - Records: 1
   - Reason: High prevalence + single record


## 🎯 **Recommendations**


### Data Quality Recommendations

#### Immediate Actions
1. **Review High-Confidence Outliers**: Manually validate diseases flagged by ≥4 methods
2. **Verify Medical Domain Flags**: Check diseases exceeding rare disease thresholds
3. **Cross-Reference Literature**: Validate extreme prevalence estimates with published data
4. **Geographic Stratification**: Separate population-specific from global estimates

#### Medium-Term Improvements
1. **Enhance Reliability Scoring**: Incorporate geographic representativeness
2. **Implement Consensus Filtering**: Use multi-method agreement for data quality
3. **Add Temporal Validation**: Check for prevalence changes over time
4. **Improve Documentation**: Flag data quality issues transparently

#### Long-Term Strategy
1. **Automated Quality Control**: Implement real-time outlier detection
2. **Expert Review Process**: Establish medical expert validation workflow
3. **Data Source Diversification**: Incorporate multiple prevalence databases
4. **Uncertainty Quantification**: Provide confidence intervals for estimates

### Filtering Recommendations

#### Conservative Approach (Recommended)
- Use **Log-Normal method** for statistical outliers
- Flag but don't remove **Medical Domain outliers**
- Require **≥2 method consensus** for exclusion
- Preserve original data with quality flags

#### Aggressive Approach (Research-Specific)
- Use **IQR method** for broader outlier removal
- Exclude **High-Confidence consensus outliers**
- Apply **Medical Domain filters** strictly
- Focus on highest-quality data only


## 📁 **Generated Files**

- `outlier_density_grid.png` - Comprehensive kernel density plot grid (3x2 panels)
- `outlier_summary_statistics.json` - Detailed statistical results
- `outlier_flagged_diseases.json` - List of flagged diseases by method
- `consensus_outliers.json` - High-confidence outliers
- `medical_domain_flags.json` - Medical domain violations

## 🔗 **Data Quality Impact**


### Impact on Dataset Quality

#### Current State
- **Total Diseases**: 4924 with prevalence estimates
- **High-Quality Diseases**: 4870 (98.9%)
- **Questionable Quality**: 54 (1.1%)

#### Filtering Impact
- **Conservative Filtering**: Removes 28 diseases (0.6%)
- **Moderate Filtering**: Removes 54 diseases (1.1%)
- **Aggressive Filtering**: Could remove up to 1047 diseases (21.3%)

#### Quality Metrics
- **Reliability Score Distribution**: 4705 diseases with reliable scores (≥6.0)
- **Multiple Records**: 4329 diseases with multiple records
- **Worldwide Coverage**: 3931 diseases with worldwide data
- **Validated Data**: 13710 total validated records

### Recommended Actions
1. **Flag High-Confidence Outliers**: Mark for manual review
2. **Stratify by Quality**: Separate high/medium/low quality datasets
3. **Transparent Reporting**: Document all filtering decisions
4. **Preserve Raw Data**: Maintain original estimates with quality flags


---

*Generated by RarePrioritizer Outlier Analysis System*  
*For questions or issues, refer to the project documentation*
